Jack A. Khattar Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Jack A. Khattar is President, CEO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.07 Million shares of SUPN, which is worth approximately $44.1 Million. The most recent transaction as insider was on Aug 06, 2025, when has been sold 140,000 shares (Common Stock) at a price of $41.79 per share, resulting in proceeds of $5,850,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.07M

6.07% 3M change

16.9% 12M change

Total Value Held $44.1 Million

Jack A. Khattar Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 06 2025	SELL Open market or private sale	$5,850,600 $41.79 p/Share	140,000 Reduced 11.57%	1,069,933 Common Stock
Aug 06 2025	BUY Exercise of conversion of derivative security	$3,439,362 $17.09 p/Share	201,250 Added 15.08%	1,133,433 Common Stock
Apr 02 2025	BUY Other acquisition or disposition	-	16,850 Added 1.64%	1,008,683 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$538,768 $32.06 p/Share	16,805 Reduced 1.67%	991,833 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	-	35,000 Added 3.35%	1,008,638 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$726,702 $39.11 p/Share	18,581 Reduced 1.87%	973,638 Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	-	38,640 Added 3.75%	992,219 Common Stock
Dec 27 2024	SELL Payment of exercise price or tax liability	$898,042 $35.59 p/Share	25,233 Reduced 2.58%	953,579 Common Stock
Dec 27 2024	BUY Exercise of conversion of derivative security	-	52,640 Added 5.2%	960,245 Common Stock
Nov 08 2024	SELL Open market or private sale	$4,536,250 $36.29 p/Share	125,000 Reduced 11.89%	926,172 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	$1,141,250 $9.13 p/Share	125,000 Added 10.63%	1,051,172 Common Stock
Nov 07 2024	SELL Open market or private sale	$4,585,000 $36.68 p/Share	125,000 Reduced 11.89%	926,172 Common Stock
Nov 07 2024	BUY Exercise of conversion of derivative security	$1,141,250 $9.13 p/Share	125,000 Added 10.63%	1,051,172 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$350,570 $34.9 p/Share	10,045 Reduced 1.07%	926,172 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	21,000 Added 2.19%	936,217 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$469,056 $27.94 p/Share	16,788 Reduced 1.8%	915,217 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	35,000 Added 3.62%	932,005 Common Stock
Feb 12 2024	BUY Other acquisition or disposition	-	16,500 Added 1.81%	897,005 Common Stock
Dec 22 2023	SELL Payment of exercise price or tax liability	$330,758 $27.66 p/Share	11,958 Reduced 1.34%	880,505 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	-	25,000 Added 2.72%	892,463 Common Stock
Sep 07 2023	SELL Payment of exercise price or tax liability	$539,408 $32.1 p/Share	16,804 Reduced 1.9%	867,463 Common Stock
Sep 07 2023	BUY Exercise of conversion of derivative security	-	35,000 Added 3.81%	884,267 Common Stock
May 11 2023	SELL Payment of exercise price or tax liability	$547,232 $36.47 p/Share	15,005 Reduced 1.74%	849,267 Common Stock
May 11 2023	BUY Exercise of conversion of derivative security	-	31,250 Added 3.49%	864,272 Common Stock
Mar 14 2023	BUY Exercise of conversion of derivative security	-	20,000 Added 2.34%	833,022 Common Stock

Also insider at

SCPH

scPharmaceuticals Inc. Healthcare

CGTX

COGNITION THERAPEUTICS INC Healthcare

Director

JAK

Jack A. Khattar

President, CEO

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Value

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN

Account